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Coronary artery disease is one of the leading causes of 
death and morbidity worldwide (1). In addition to classic 
cardiovascular risk factors, age is the strongest risk factor of 
coronary artery disease, as well as an independent predictor 
of poor outcomes following an acute coronary syndrome (2). 
In the last decades we are witnessing a notable rise in life 
expectancy. Thanks to healthcare improvements, many 
diseases have become chronic processes, so the rise in life 
expectancy has been accompanied by a parallel increase in 
patients’ comorbidities (3,4), which imposes a challenge in 
their treatment.
Non-ST segment elevation acute coronary syndrome 
(NST-ACS) is the most common presentation of acute 
myocardial infarction (approximately 3 out of 4 patients), 
especially in the elderly (2,5). Near 40% of patients 
presenting a NST-ACS are ≥75-year-old (2). Despite this 
high prevalence, older patients are underrepresented in 
clinical trials addressing the efficacy of acute coronary 
syndrome therapies (6,7), so there is great uncertainty 
regarding the best treatment options in this scenario. 
Moreover, polypharmacy, which is common in the elderly, 
predisposes to adverse effects and pharmacological 
interactions, so usual medications may have a detrimental 
impact on comorbidities (such as statins on myopathy, or 
beta-blockers aggravating obstructive lung disease) (8). 
Regarding coronary angiography, which is the preferred 
strategy in patients presenting an acute coronary syndrome (9), 
there are few studies addressing the potential benefit of an 
invasive approach in octogenarians presenting a NST-ACS (10), 
as this is a heterogeneous group. 
In this issue of the Journal, Sui et al. (11) report gender 
impact on treatment effectiveness and survival in very 
elderly patients admitted due to an NST-ACS. This is 
an interesting but retrospective analysis of consecutive 
patients with NST-ACS from a single center in China. 
Baseline characteristics, comorbidities and relevant 
conditions were collected and compared among patients 
who underwent invasive and conservative strategies in men 
and women. However, a detailed direct comparison of 
baseline characteristics and clinical outcomes between men 
and women with NST-ACS was not performed. Overall, 
the invasive treatment was associated with a reduction 
in mortality in both genders. However, after adjusting 
for potential confounders the invasive strategy was only 
associated with a better survival in men, but not in women. 
Interestingly the survival curves keep diverging beyond the 
second year in men further suggesting the long-term benefit 
of revascularization in this cohort. Although these findings 
would suggest that an invasive strategy is less likely to confer 
a clinical benefit in women, some important methodological 
issues should be considered. First, the sample size was very 
limited (and the proportion of women was markedly low, 
near one third) and this seriously limits the robustness of the 
findings. This is of special concern considering the multiple 
subgroups analyses and also the endpoint of mortality 
selected. The study is largely unpowered in this regard. 
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Second, many unmeasured confounders may have played a 
major role in the differences between genders. As women 
tend to have more adverse baseline clinical and anatomic 
characteristics it is also likely that other important adverse 
characteristics and comorbidities would be more frequent 
in women yet would have been overlooked due to the 
retrospective nature of the study. This gender gap has also 
been reported in previous studies (12-15), associating lower 
invasive treatment including coronary angiography and 
revascularization, antiplatelet drugs, and other secondary 
prevention medications in women (16). These two concerns, 
namely small sample size and the retrospective and 
observational design suggest that the study findings should 
be considered at most as hypothesis generating. However, 
some randomized and real-life studies have showed that 
revascularization is clearly beneficial in elderly women, with 
a reduction in 1-year mortality, and without a significant 
increase in adverse effects (especially major bleeding) (15). 
After adjusting for age and comorbidities, women tend to 
have an improved survival compared with men (12,14). 
Furthermore, previous studies have consistently 
demonstrated that women had more adverse anatomic 
features for percutaneous coronary interventions. However, 
lesions characteristics, and particularly vessel size, were 
not evaluated in the current study. Moreover, whether a 
similar rate of complete revascularization was achieved 
in both groups remains unclear. Additionally, bleeding 
complications are classically more frequent in women and in 
elderly patients in general but, unfortunately, this important 
information was not collected in this study. Apparently, new 
potent platelet inhibitors were not used in this study. The 
potential influence of dual antiplatelet therapy (DAPT) and 
a radial access in this regard merit further investigation in 
octogenarians presenting with NST-ACS.
On the other hand, in recent years, frailty has emerged 
as a concept of great value to guide treatment, and clarify 
the prognosis in elderly patients (17). Frailty, defined as 
a state of vulnerability with reduced capacity to respond 
and adapt to external stressors (18,19), is very common in 
elderly patients (18). Frailty and acute coronary syndrome 
often coexist (19,20), entailing higher mortality and 
less use of invasive treatment, and subsequent coronary 
revascularization (20,21). Frailty assessment should be 
mandatory in patients presenting a NST-ACS, as it is a 
powerful predictor of poor outcomes, with higher mortality 
and readmissions (22), though there is uncertainty about the 
most appropriate management regarding invasive coronary 
intervention in frail elderly patients (23). However, it is 
not routinely measured in daily clinical practice (19), and 
was not taken into account in the work of Sui et al. (11). It 
is uncertain whether the differences in treatment response 
by sex are explained by biological factors and gender 
particularities per se, or inequity in the administration of 
therapies and patients’ selection. We could assume that the 
minor benefit derived from the invasive treatment observed 
in the group of elderly women with NST-ACS (11) could 
be attributed, at least in part, to a higher prevalence of 
frailty in this group, compared to men. 
Finally, with respect to the definition of endpoints of 
studies focused in elderly patients, mortality alone may 
not be appropriate, as the impact of a specific therapy 
or intervention on survival may be low. Quality of life-
based endpoints, hospital readmissions, complications, and 
dependence in the medium-term may be more appropriate.
More studies are eagerly needed to establish the value of 
an invasive strategy in elderly women with NST-ACS. In 
the meantime, the potential benefit of an invasive strategy 
should be offered to elder women presenting with NST-
ACS after a careful holistic (cardiac and geriatric) clinical 
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